Endocyte's Series C - II Round

Endocyte raised a round of funding on December 17, 2004.

Endocyte is a biotechnology company developing receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. The Company focuses on certain types of cancer cells…

Articles about Endocyte's Series C - II Round: